Moreover, ALB has anti-inflammatory and antioxidant functions (Yang et al., 2021), while NAFLD patients exhibited lower ALB levels due to hepatic lipid accumulation, which might exacerbate the progression of liver inflammation (Peiseler et al., 2022; Li et al., 2024b). This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.